Early diagnosis of congenital copper metabolic disorder Wilson disease

Early diagnosis of congenital copper metabolic disorder Wilson disease - Early diagnosis of Wilson disease

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021617

Enrollment

Registered

2016-03-28

Start date

2021-03-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wilson disease

Interventions

Intervention:liver biopsy, one or two times at pre- and post-treatment to evaluate routine histological diagnostic purpose (in such case, residual specimens will be used as observational study). How

s clear understanding and positive agreement with informed consent about the needs of biopsy and enrolment in this study. No intervention for type of drug usage.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Wilson disease (& suspected cases) by liver tests and copper metabolic tests

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
Copper content and distribution in livers of Wilson disease, use biopsied specimens at pre- and post-drug treatment.	—

Secondary

Measure	Time frame
Copper content and distribution in livers of non-Wilson disease (WD suspected cases and idiopathic copper toxicosis)	—

Countries

Japan,Asia(except Japan)

Contacts

Public ContactAkihiro Matsuura

Fujita Health University Research Integrity Office, Quantum Beam Diagnostics

amatsuu@fujita-hu.ac.jp0562-93-2786

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026